T-cell receptor repertoire of cytomegalovirus-specific cytotoxic T-cells after allogeneic stem cell transplantation.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
17 12 2020
Historique:
received: 28 05 2020
accepted: 08 12 2020
entrez: 18 12 2020
pubmed: 19 12 2020
medline: 11 5 2021
Statut: epublish

Résumé

Cytomegalovirus (CMV) infection is a major complication during allogeneic stem cell transplantation (allo-SCT). However, mechanisms of adaptive immunity that drive this remain unclear. To define early immunological responses to CMV after transplantation, we using next-generation sequencing to examine the repertoire of T-cell receptors in CD8

Identifiants

pubmed: 33335252
doi: 10.1038/s41598-020-79363-2
pii: 10.1038/s41598-020-79363-2
pmc: PMC7747720
doi:

Substances chimiques

Biomarkers 0
Receptors, Antigen, T-Cell 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

22218

Références

Biol Blood Marrow Transplant. 2018 Jan;24(1):13-18
pubmed: 29032062
J Immunol. 2005 Nov 1;175(9):6123-32
pubmed: 16237109
Biol Blood Marrow Transplant. 2015 Nov;21(11):2008-16
pubmed: 26211985
JCI Insight. 2016;1(5):
pubmed: 27213183
Rinsho Ketsueki. 2018;59(10):2373-2379
pubmed: 30305548
J Immunol Methods. 2007 Apr 10;321(1-2):182-95
pubmed: 17337271
Nat Genet. 2017 May;49(5):659-665
pubmed: 28369038
Blood. 2020 Feb 27;135(9):620-628
pubmed: 31942610
Cell Rep. 2017 Apr 18;19(3):569-583
pubmed: 28423320
Blood. 2003 Jan 15;101(2):407-14
pubmed: 12393659
Front Immunol. 2018 Apr 10;9:760
pubmed: 29692783
Blood. 2016 May 19;127(20):2427-38
pubmed: 26884374
J Immunol. 2016 Jun 15;196(12):5005-13
pubmed: 27183615
Cell Rep. 2019 Oct 22;29(4):810-815.e4
pubmed: 31644905
Blood. 2006 Mar 15;107(6):2373-83
pubmed: 16322475
Clin Exp Immunol. 2016 Jun;184(3):389-402
pubmed: 26800118
Sci Transl Med. 2012 Apr 4;4(128):128ra42
pubmed: 22491952
Biol Blood Marrow Transplant. 2019 Mar;25(3):417-423
pubmed: 30359734
BMC Immunol. 2019 Jun 21;20(1):19
pubmed: 31226930
Ann Hematol. 2015 Oct;94(10):1707-15
pubmed: 26193851
Bone Marrow Transplant. 2015 Sep;50(9):1227-34
pubmed: 26052909
Bone Marrow Transplant. 2007 Jul;40(2):125-36
pubmed: 17530009
Expert Rev Hematol. 2019 Nov;12(11):937-945
pubmed: 31423858
Blood. 2000 Jan 1;95(1):352-9
pubmed: 10607724
Bone Marrow Transplant. 2014 Jan;49(1):87-94
pubmed: 23933763
Bone Marrow Transplant. 2017 Jun;52(6):811-817
pubmed: 28287639
Bone Marrow Transplant. 2018 Oct;53(10):1351-1355
pubmed: 29740181
J Clin Oncol. 2017 Nov 1;35(31):3547-3557
pubmed: 28783452
Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2034-9
pubmed: 18238896
Blood. 2015 Jun 18;125(25):3835-50
pubmed: 25852054
Nucleic Acids Res. 2020 Jan 8;48(D1):D1057-D1062
pubmed: 31588507
Front Immunol. 2018 Nov 14;9:2539
pubmed: 30487790
Blood Adv. 2020 Mar 24;4(6):1051-1061
pubmed: 32191806
Leukemia. 2020 May;34(5):1422-1432
pubmed: 31772297
Leukemia. 2017 Oct;31(10):2161-2171
pubmed: 28090089
Front Immunol. 2016 Sep 06;7:345
pubmed: 27656185
Genome Res. 2004 Jun;14(6):1188-90
pubmed: 15173120
Lancet Infect Dis. 2019 Aug;19(8):e260-e272
pubmed: 31153807
Immunol Rev. 2018 Jul;284(1):167-179
pubmed: 29944757
J Hum Genet. 2015 Nov;60(11):683-90
pubmed: 26202576
Nat Med. 2013 Mar;19(3):372-7
pubmed: 23435170
Blood. 2013 Aug 15;122(7):1316-24
pubmed: 23744585
Bioinformatics. 2009 May 1;25(9):1189-91
pubmed: 19151095
Biol Blood Marrow Transplant. 2019 May;25(5):868-882
pubmed: 30677510
Blood. 2013 Jun 13;121(24):4955-62
pubmed: 23652802
J Virol. 2015 Jan;89(1):110-9
pubmed: 25320304
Sci Rep. 2017 Jun 16;7(1):3663
pubmed: 28623251
Biol Blood Marrow Transplant. 2009 Mar;15(3):367-9
pubmed: 19203728
Haematologica. 2019 Mar;104(3):622-631
pubmed: 30262565
Sci Transl Med. 2015 Dec 9;7(317):317ra198
pubmed: 26659572
BMC Immunol. 2016 Oct 11;17(1):38
pubmed: 27729009
N Engl J Med. 2017 Dec 21;377(25):2433-2444
pubmed: 29211658
Nucleic Acids Res. 2004 Mar 19;32(5):1792-7
pubmed: 15034147
Leukemia. 2020 Mar;34(3):831-844
pubmed: 31624377
Biol Blood Marrow Transplant. 2014 Jan;20(1):46-52
pubmed: 24120526
PLoS One. 2019 Sep 30;14(9):e0223258
pubmed: 31568490
Cancer Immunol Immunother. 2020 Aug;69(8):1535-1548
pubmed: 32300857
J Clin Invest. 2016 Jun 1;126(6):2093-108
pubmed: 27111229
Lancet Haematol. 2016 Mar;3(3):e119-27
pubmed: 26947200

Auteurs

Takashi Toya (T)

Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan. tooya-tky@umin.ac.jp.

Ayumi Taguchi (A)

Department of Obstetrics and Gynecology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. aytaguchi-tky@umin.ac.jp.
Department of Gynecology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan. aytaguchi-tky@umin.ac.jp.

Kazutaka Kitaura (K)

Repertoire Genesis Inc., Ibaraki, Japan.

Fumi Misumi (F)

Department of Obstetrics and Gynecology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Yujiro Nakajima (Y)

Department of Radiation Oncology, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan.
Radiation Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Yuki Otsuka (Y)

Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.

Ryosuke Konuma (R)

Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.

Hiroto Adachi (H)

Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.

Atsushi Wada (A)

Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.

Yuya Kishida (Y)

Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.

Tatsuya Konishi (T)

Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.

Akihito Nagata (A)

Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.

Yuta Yamada (Y)

Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.

Atsushi Marumo (A)

Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.

Yuma Noguchi (Y)

Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.

Kota Yoshifuji (K)

Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.

Junichi Mukae (J)

Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.

Kyoko Inamoto (K)

Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.

Aiko Igarashi (A)

Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.

Yuho Najima (Y)

Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.

Takeshi Kobayashi (T)

Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.

Kazuhiko Kakihana (K)

Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.

Kazuteru Ohashi (K)

Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.

Ryuji Suzuki (R)

Repertoire Genesis Inc., Ibaraki, Japan.

Takeshi Nagamatsu (T)

Department of Obstetrics and Gynecology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Noriko Doki (N)

Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH